Compare Fiverr International Ltd (FVRR) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fiverr International Ltd vs IDEXX Laboratories, Inc. — how do they compare? Fiverr International Ltd trades at $8.59 (market cap $310.61M), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 130.2× Fiverr International Ltd's market cap, and IDEXX Laboratories, Inc. is more actively traded (692,164 versus 381,459). Which is the better fit depends on your goals — on Pluang, investors hold Fiverr International Ltd for 62 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| FVRR | IDXX | |
|---|---|---|
Market Cap | $310.61M | $40.43B |
Volume | 381,459 | 692,164 |
Sector | Media | Health |
52-Week High | $23.60 | $766.68 |
52-Week Low | $8.47 | $504.70 |
Typical Hold Time | 62 Days | 46 Days |
Enterprise Value | $63.00M | $41.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Fiverr International (FVRR) trades at $8.68, up 2.12% with bearish technical signals despite attractive valuation metrics including a P/E of 10.67 and P/S of 0.76. Recent earnings show mixed results with Q2 2026 missing estimates, while revenue growth has slowed from 2025's $431M to projected $418M in 2026. The company faces AI disruption pressures but maintains strong gross margins of 82% and positive net income.
The outlook remains cautious with analysts predominantly holding neutral ratings (76% Hold) and a $10.50 price target suggesting modest upside. Key risks include AI competition compressing freelance demand, while potential exists if Fiverr successfully adapts its platform to AI-driven market changes. Current valuation appears reasonable for patient investors despite near-term headwinds.
IDEXX Laboratories (IDXX) trades at $519.87, up 2.61% on the day, with a bearish technical signal from moving averages but strong fundamentals including a 25.03% net income margin and consistent earnings beats. Revenue grew to $4.3B in 2025, and the company recently acquired CoVetAI to enhance veterinary workflow intelligence, signaling strategic expansion.
The stock's outlook is supported by robust profitability and analyst consensus, but faces headwinds from technical weakness and potential market volatility. With a $665 price target implying significant upside, the primary risks include competitive pressures and execution of growth initiatives amid economic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fiverr International Ltd
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
